Skip to content

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has strengthened its leadership team with two new additions to its Senior Leadership Team.

Walter Tyrrell has been appointed as chief financial officer and Robert O’Beirn as senior vice president and commercial director.  Mr. O’Beirn takes interim responsibility for Sharp’s European commercial packaging operation, while also leading corporate development overall for the division.

Commenting on the appointments, Brendan McAtamney, CEO of UDG Healthcare, said:

“I am very pleased to welcome Robert and Walter to Sharp’s senior leadership team. Their skill and experience will be instrumental in helping us to continue delivering growth for the Sharp division and developing services that meet our customers’ evolving needs.”

Mr. Tyrrell moves to Sharp from within the wider UDG Healthcare group, where he has been Head of Internal Audit since 2014.  Prior to joining UDG Healthcare, Walter held senior roles in the banking and life assurance sectors.

Mr O’Beirn joined UDG Healthcare in 2011 as senior legal counsel, later joining the corporate development area, with particular focus on M&A.

ABOUT SHARP

Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, Sharp has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. Sharp is also a world leader in ’Track and Trace’ and serialization services, with over 11 years’ experience in implementing serialized solutions for its pharma clients.

Related Resources

Happy World Environment Day! To mark today, UDG Healthcare officially introduced its Sustainability Champions' Network to employees globally.
#sustainability #environment #worldenvironmentday2021 #ESG

New Manufacturing Site in South Wales to Create 300 New Jobs - Innova Medical Group, has announced an initial investment in South Wales to start producing millions of COVID lateral flow tests per day in the UK. @Sharp_Services
https://businessnewswales.com/new-manufacturing-site-in-south-wales-to-create-300-new-jobs/

“Wales welcomes Innova’s investment & the 100s of new job opportunities it creates, boosting the local economy & further enhancing Wales’ reputation in the life sciences sector” @vaughangething

More good news & job creation for Wales

@Sharp_Services

https://businessnewswales.com/new-manufacturing-site-in-south-wales-to-create-300-new-jobs/